Stability of cannabidiol, ∆9-tetrahydrocannabinol, and cannabinol under stress conditions

被引:0
|
作者
Jiroj Yangsud
Supadit Santasanasuwan
Pongphop Ahkkarachinoreh
Athip Maha
Fameera Madaka
Jirapornchai Suksaeree
Thanapat Songsak
Arthimond Vutthipong
Chaowalit Monton
机构
[1] Rangsit University,College of Pharmacy
[2] Rangsit University,Medicinal Cannabis Research Institute, College of Pharmacy
[3] Rangsit University,Drug and Herbal Product Research and Development Center, College of Pharmacy
[4] Rangsit University,Department of Pharmaceutical Chemistry, College of Pharmacy
[5] Rangsit University,Department of Pharmacognosy, College of Pharmacy
来源
关键词
Cannabinoids; Cannabis; Method validation; Stability; Stress test;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this work was to validate a high-performance liquid chromatography (HPLC) method for determination of the stability of cannabidiol, ∆9-tetrahydrocannabinol, and cannabinol. Furthermore, degradation kinetics were also investigated. Five stress conditions—acid degradation, alkaline degradation, oxidation, thermal degradation, and photodegradation—were evaluated. The results showed that the HPLC method had a linear response (R2 ≥ 0.9999) in the test range of 1–200 µg/mL. The method was specific, precise, and accurate. The limits of both detection and quantitation are also reported. According to the stress test, the three cannabinoids (cannabidiol, ∆9-tetrahydrocannabinol, cannabinol) were stable during exposure to a range of thermal conditions for 24 h. They were unstable when being subjected to acid conditions; cannabidiol under alkaline conditions was extremely unstable. Degradation kinetic analysis demonstrated that the compounds remained at a level of approximately 8% after 5 h, and approached a first-order reaction (R2 = 0.9930) with a rate constant of − 0.5057 h− 1. In summary, the obtained data can be used as a guide for the formulation development of cannabis products in order to maintain their active compounds as well as their activities.
引用
收藏
页码:475 / 484
页数:9
相关论文
共 50 条
  • [21] EFFECT OF DELTA-9-TETRAHYDROCANNABINOL, CANNABIDIOL AND CANNABINOL ON ETHER ANESTHESIA IN MICE
    MALOR, R
    JACKSON, DM
    CHESHER, GB
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (08) : 610 - 612
  • [22] INTERACTIONS IN MAN OF DELTA-9-TETRAHYDROCANNABINOL .2. CANNABINOL AND CANNABIDIOL
    HOLLISTER, LE
    GILLESPIE, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 18 (01) : 80 - 83
  • [23] Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity
    Lisa-Marie Greenwood
    Samantha J. Broyd
    Hendrika H. van Hell
    Juanita Todd
    Alison Jones
    Robin M. Murray
    Rodney J. Croft
    Patricia T. Michie
    Nadia Solowij
    Psychopharmacology, 2022, 239 : 1409 - 1424
  • [24] Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice
    Liu, Junhan
    Scott, Brian W.
    Burnham, Willets McIntyre
    BEHAVIOURAL PHARMACOLOGY, 2022, 33 (2-3): : 206 - 212
  • [25] Selective inhibition of Δ9-tetrahydrocannabinol metabolite formation by cannabidiol in vitro
    McArdle, K
    Mackie, P
    Pertwee, R
    Guy, G
    Whittle, B
    Hawksworth, G
    TOXICOLOGY, 2001, 168 (01) : 133 - 134
  • [26] Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
    Douglas L Boggs
    Jacques D Nguyen
    Daralyn Morgenson
    Michael A Taffe
    Mohini Ranganathan
    Neuropsychopharmacology, 2018, 43 : 142 - 154
  • [27] Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
    Rao, Qianru
    Zhang, Ting
    Dai, Manyun
    Li, Bin
    Pu, Qianlun
    Zhao, Min
    Cheng, Yan
    Yan, Dongmei
    Zhao, Qi
    Wu, Zhanxuan E.
    Li, Fei
    MOLECULES, 2022, 27 (21):
  • [28] Cannabidiol does not convert to Δ9-tetrahydrocannabinol in an in vivo animal model
    Wray, Louise
    Stott, Colin G.
    Jones, Nicholas A.
    Wright, Stephen
    NEUROLOGY, 2017, 88
  • [29] Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
    Boggs, Douglas L.
    Nguyen, Jacques D.
    Morgenson, Daralyn
    Taffe, Michael A.
    Ranganathan, Mohini
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (01) : 142 - 154
  • [30] Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft
    Leelawat, Surang
    Leelawat, Kawin
    Wannakup, Thaniya
    Saingam, Worawan
    Khamthong, Nanthaphong
    Madaka, Fameera
    Maha, Athip
    Pathompak, Patamaporn
    Sueree, Lukman
    Songsak, Thanapat
    ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2022, 12 (08) : 323 - 332